Global Endorphins Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Endorphins Market Research Report 2024
Endorphins are also known as “feel-good” or natural pain relievers. They are produced by the central nervous system and pituitary gland. Endorphins are released in response to stress or pain. They work similarly to a class of drugs called opioids. However, endorphins work similarly to opioid pain reliver, but their result may not dramatic. Besides, they are also released during other activities such as exercise, eating and others activities. Endorphins are also surge during pregnancy. Further, there are various medicinal herbs such as Rhodiola roseal, is known to release beta-endorphins in the brain and also used against an anti-depressant.
According to Mr Accuracy reports’s new survey, global Endorphins market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Endorphins market research.
Key manufacturers engaged in the Endorphins industry include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Endo International Plc, Egalet Corp., Lannett Co. Inc., Pfizer and Johnson & Johnson, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Endorphins were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Endorphins market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Endorphins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Endo International Plc
Egalet Corp.
Lannett Co. Inc.
Pfizer
Johnson & Johnson
Segment by Type
Alpha-Endorphins
Beta-Endorphins
Gamma-Endorphins
Sigma-Endorphins
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Endorphins report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Endorphins market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Endorphins market research.
Key manufacturers engaged in the Endorphins industry include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Endo International Plc, Egalet Corp., Lannett Co. Inc., Pfizer and Johnson & Johnson, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Endorphins were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Endorphins market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Endorphins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Endo International Plc
Egalet Corp.
Lannett Co. Inc.
Pfizer
Johnson & Johnson
Segment by Type
Alpha-Endorphins
Beta-Endorphins
Gamma-Endorphins
Sigma-Endorphins
Segment by Application
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Endorphins report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices